Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies

Loading video...

391 Views

Air date: Thursday, January 20, 2022, 12:00:00 PM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 391 (310 Live, 81 On-demand)
Category: COVID-19
Runtime: 00:59:27
Description: COVID-19 Lecture Matthew Snape, MBBS FRCPCH MD, is an Professor in General Paediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Paediatrician at the Children’s Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity.

For more information go to https://www.niaid.nih.gov/research/covid-19-sig
NLM Title: Heterologous prime/boost COVID-19 vaccine schedules : emerging data from the COM-COV and COM-boost studies / Matthew Snape.
Author: Snape, Matthew.
National Institutes of Health (U.S.). COVID-19 Scientific Interest Group,
Publisher:
Abstract: (CIT): Matthew Snape, MBBS FRCPCH MD, is an Professor in General Pediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Pediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Pediatrician at the Children's Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity.
Subjects: COVID-19 Vaccines--administration & dosage
COVID-19 Vaccines--immunology
COVID-19--drug therapy
Immunization Schedule
Immunization, Secondary
Vaccine Efficacy
Publication Types: Lecture
Webcast
 
NLM Classification: WC 506.6
NLM ID: 9918351572506676
CIT Live ID: 44521
Permanent link: https://videocast.nih.gov/watch=44521

Related Videos...

Click Here to Play Video.
03:59:26
Robotic Medicine: Dr. R2D2 Will See You Now
[STEP (HHS Only)]
5/10/2007
Click Here to Play Video.
08:23:11
Bringing Therapeutic Cancer Vaccines and Immunotherapies Through Development to Licensure (Day 1)
[Conferences]
2/8/2007
Click Here to Play Video.
06:28:24
Cancer and Inflammation - Day 1
[HHS Only]
10/9/2007
Click Here to Play Video.
06:54:36
Cancer Immunology and Immunotherapy: Realizing the Promise (Day 1) (HHS-Only)
[HHS Only]
9/11/2008
Click Here to Play Video.
06:43:50
Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 1
[Advisory Boards and Councils]
10/29/2009
Click Here to Play Video.
04:48:12
National Vaccine Advisory Committee (NVAC) Meeting (Day 2)
[Advisory Boards and Councils]
9/16/2009
Click Here to Play Video.
07:41:09
Recombinant DNA Advisory Committee (RAC) (Day 2)
[Recombinant DNA Advisory Committee]
12/15/2000
Click Here to Play Video.
05:02:11
National Advisory Research Resources Council - September 2010
[Advisory Boards and Councils]
9/14/2010
Click Here to Play Video.
06:28:51
The Interagency Autism Coordinating Committee - October 2010
[Interagency Autism Coordinating Committee]
10/22/2010
Click Here to Play Video.
08:14:11
INCLUDE Project: Clinical Trials in Down Syndrome Workshop (Day 1)
[Conferences]
5/7/2020